MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Danaher Corporation EBITDA per Share 2011-2026 | DHR
Annual EBITDA per Share Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.63 | 7.64 | 7.98 | 11.4 | 11.8 | 8.5 | 6.24 | 6.72 | 6.12 | 5.61 | 6.48 | 6.22 | 5.99 | 5.67 | 4.71 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.8 | 4.71 | 7.25 |
Quarterly EBITDA per Share Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.03 | - | 2.01 | - | - | 3.03 | 3.28 | - | 1.83 | 3.28 | 3.02 | - | 2.18 | 1.63 | 1.2 | 1.38 | 1.66 | 1.52 | 1.21 | 1.23 | 1.7 | 1.52 | 1.2 | 1.35 | 1.7 | 1.38 | 1.09 | 1.05 | 1.58 | 1.41 | 1.08 | 0.95 | 1.2 | 1.21 | 0.82 | 1.23 | 1.81 | 1.64 | 1.24 | 1.22 | 1.68 | 1.53 | 1.16 | 1.26 | 1.62 | 1.52 | 1.24 | 1.13 | 1.27 | 1.07 | 0.96 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.28 | 0.82 | 1.55 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
5.49 | $ 111.16 | -2.04 % | $ 33.8 B |  USA |
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Sotera Health Company
SHC
|
0.33 | $ 13.26 | -2.07 % | $ 3.77 B | USA |
 |
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M |  Israel |
|
Biodesix
BDSX
|
-0.22 | $ 14.28 | -2.19 % | $ 1.85 B | USA |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
BioNano Genomics
BNGO
|
-4.37 | $ 1.14 | -1.3 % | $ 6.21 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 16.25 | -12.16 % | $ 175 M |  China |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-0.28 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | USA |
 |
Co-Diagnostics
CODX
|
-1.41 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Castle Biosciences
CSTL
|
0.89 | $ 24.03 | -2.71 % | $ 667 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 158.22 | -4.18 % | $ 7.84 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 196.67 | -0.75 % | $ 21.8 B | USA |
 |
Organovo Holdings
ONVO
|
-8.44 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
0.11 | - | -16.95 % | $ 1.54 M | USA |
 |
DarioHealth Corp.
DRIO
|
-9.13 | $ 8.45 | - | $ 33.7 M | Israel |
 |
DexCom
DXCM
|
2.98 | $ 62.38 | -5.61 % | $ 24.3 B | USA |
 |
Fulgent Genetics
FLGT
|
-1.62 | $ 15.72 | -4.06 % | $ 475 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
-3.17 | $ 84.78 | -3.77 % | $ 10.6 B | USA |
 |
PerkinElmer
PKI
|
6.54 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M | USA |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 102.7 | -0.37 % | $ 8.47 B |  Irlanda |
 |
Illumina
ILMN
|
-3.01 | $ 118.42 | -4.81 % | $ 18.8 B | USA |
 |
Interpace Biosciences
IDXG
|
1.92 | $ 1.68 | -2.89 % | $ 7.37 M | USA |
 |
IQVIA Holdings
IQV
|
19.4 | $ 165.13 | -2.52 % | $ 28.4 B | USA |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 74.66 | -2.23 % | $ 5.04 B | USA |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
1.35 | - | - | $ 10.6 B |  Niderland |
 |
Medpace Holdings
MEDP
|
19.5 | $ 455.39 | -2.4 % | $ 13.1 B | USA |
 |
Mettler-Toledo International
MTD
|
2.48 | $ 1 240.08 | -2.36 % | $ 25.6 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 4.43 | -4.22 % | $ 410 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-20.1 | $ 4.7 | 2.4 % | $ 2.52 M | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 7.55 | -2.77 % | $ 967 M | USA |
 |
Neogen Corporation
NEOG
|
-4.34 | $ 8.85 | -3.33 % | $ 1.92 B | USA |
 |
National Research Corporation
NRC
|
1.35 | $ 17.23 | -0.78 % | $ 386 M | USA |
 |
Celcuity
CELC
|
-3.68 | $ 108.87 | -5.06 % | $ 5.09 B | USA |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |